Rocket Pharmaceuticals
RCKT
RCKT
190 hedge funds and large institutions have $1.71B invested in Rocket Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 67 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.35% more ownership
Funds ownership: 100.51% → 101.86% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
13% less capital invested
Capital invested by funds: $1.96B → $1.71B (-$255M)
Holders
190
Holding in Top 10
4
Calls
$4.96M
Puts
$1.39M
Top Buyers
| 1 | +$38.5M | |
| 2 | +$20.3M | |
| 3 | +$19.7M | |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$6.42M |
| 5 |
State Street
Boston,
Massachusetts
|
+$5.95M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$15.4M | |
| 3 | -$12.4M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$10.9M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$6.48M |